1 / 26

Building Economic Wealth through New Zealand's Bioeconomy

Welcome to the New Zealand Bioeconomy Summit 2009, where we will discuss the development and future of New Zealand's bioeconomy. Our key objectives include defining a vision for a sustainable bioeconomy, identifying areas of competitive advantage, and developing recommendations for achieving our vision.

aitana
Download Presentation

Building Economic Wealth through New Zealand's Bioeconomy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. NEW ZEALAND BIOECONOMY SUMMITJUNE 3, 2009 BUILDING ECONOMIC WEALTH FOR NEW ZEALAND THROUGH A BROAD BASED BIOECONOMY

  2. INTRODUCTION • Welcome & Thank you! • Key Objectives: • Comment on the development of the broader bioeconomy since the original Biotechnology Taskforce was convened in 2002; • Define a vision of what a sustainable and prosperous bioeconomy in New Zealand would look like in 2015; • Identify areas of competitive advantage and significant economic gain for New Zealand; and • Develop recommendations, which will enable New Zealand to achieve the identified vision, including immediate, medium and long-term recommendations.

  3. OUTCOMES • A definitive report on the importance of the bioeconomy to New Zealand’s future economic prosperity • Clear recommendations for the short, medium & long term as to how New Zealand can capture maximum benefit from the bioeconomy • A clear foundation for NZBIO to proactively undertake policy and advocacy initiatives over the next 5 years

  4. BIOTECHNOLOGY TASKFORCE 2002REVIEW OF PROGRESS & OUTCOMES

  5. THE TASKFORCE • In 2002 the former Labour-led Government released the Growth Innovation Framework • Three key areas of high growth potential were identified: • Information & Communications Technology • Creative Industries • Biotechnology • The 2002 Taskforce was convened to identify strategies for building New Zealand’s biotechnology industry • The resulting framework had six key areas of focus: • People • Funding • Institutions • Infrastructure • Regulations • Global Participation

  6. PEOPLE

  7. FUNDING

  8. INSTITUTIONS

  9. INFRASTRUCTURE

  10. REGULATIONS

  11. REGULATIONS (cont)

  12. GLOBAL PARTICIPATION

  13. GLOBAL PARTICIPATION

  14. LOOKING FORWARD • Since 2002 there has been a lot of activity by various organisations to deliver on taskforce recommendations • In order to move the NZ bioeconomy forward a new strategy, building on the established foundations, needs to be established to guide future programmes & projects • This is a key outcome expected of the 2009 Bioeconomy Summit

  15. NEW ZEALAND BIOTECHNOLOGY INDUSTRY OVERVIEW 2008 BIOTECHNOLOGY INDUSTRY GROWTH REPORT PREVIEW Bronwyn Dilley Chief Executive, NZBIO

  16. NZ BIOTECH INDUSTRY GROWTH REPORT 2008 • Launched today • Late release due to issues with underlying survey & significant work with Statistics New Zealand to enable release of key data • Self-Selected Organisations • Core biotech Orgs: Products & Services are biotechnology based • Biotech Active: Utilises Biotechnology in the development of products and services • 2009 Survey will be undertaken in second half of this year

  17. ORGANISATIONS • 33% increase in number of organisations • Total of 168 Organisations in 2007 • 36 Research Sector • 39 Active • 90 Core Biotechnology Organisations

  18. EMPLOYMENT • 78% increase in core biotechnology sector employees • Primarily in PhD & Tertiary qualified employees

  19. INCOME • 23% per annum growth in total income • $276m income generated in 2007 • Net profit of the sector has more than doubled since 2005

  20. EXPORTS • Export revenues increased by over 35% per annum • Export revenues totalled $104m in 2007 • Multiplier effect: 2.41 jobs created in the broader economy for every full time job in the biotech sector

  21. FUNDING • 23 VC & PE Deals in 2007 representing $67m (almost triple investment in 2005) • Primary focus on human health & food biotechnology (>30 deals 2005-2007) • Total VC & PE funding in NZ is increasing with the primary investment area being health/ biosciences

  22. INTELLECTUAL PROPERTY • Patent volume has increased 9% p.a. • 230 patents granted 2005-2007 • ~75 organisations released new or significantly improved products & services in 2005-2007

  23. APPLICATIONS • The sector is broad based spanning the entire bioeconomy • Animal Based Biotech • Plant Based Biotech • Innovative Foods • Bioprocessing/ biomanufacturing • Marine Biotech • Environmental Biotech • Biomedical Science • Integration of emerging technology

  24. CONSTRAINTS IDENTIFIED

  25. CONCLUSION • The 2008 BIG report shows across the board increases in activity and outcomes of bio-based organisations since 2005 • Key improvements have been made to the industry survey to improve quality of data in future years • Building on the industry knowledge and developments since 2002 – How do we take it to the next level?

  26. TODAY’S AGENDA • Update from NZTE, MED & MoRST on the Government landscape under the new National-Led Government • Discussion regarding international trends & developments • Identifying opportunities & challenges for the NZ sector • Day 2: Developing strategies and recommendations

More Related